TWST Earnings Results and History
Twist Bioscience Corp's earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- EPS−$0.32 vs −$0.39 est +17.3%
- Revenue$126.6M vs $123.5M est +2.5%
- Revenue growth+27.9% vs a year ago
- Outlook InitiatedNext quarter: $130M to $132M revenue
FY2027: $550M to $560M revenue
Filed ยท Press release
Key takeaways
from the press release- Q4 FY2026 revenue rose 28% to $126.6M, the 15th straight quarter of sequential growth.
- Q4 adjusted EBITDA was positive at $2.2M, versus a $7.8M loss a year earlier.
EPS by quarter
GAAP diluted, 12 quartersRevenue and operating margin
from 10-Q and 10-KQuarter by quarter
from 10-Q and 10-K filings| Quarter ended | Revenue | Growth | Gross margin | Op margin | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2026 | $126.6M | +27.9% | 53.1% | −19.3% | −$20.6M | −$0.30 | −$20.1M |
| Jun 2026 | $118.4M | +23.2% | 52.8% | −30.6% | −$35.1M | −$0.56 | −$8.6M |
| Mar 2026 | $110.7M | +19.3% | 51.6% | −41.4% | −$44M | −$0.71 | −$25.4M |
| Dec 2025 | $103.7M | +16.9% | 52.0% | −31.7% | −$30.5M | −$0.50 | −$34.8M |
EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.
Reports and price reactions
last 1 reportsYear by year
fiscal years, from 10-K filings| Year ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Sep 30, 2026 | $459.4M | +22.0% | −30.4% | −$130.2M | −$2.08 |
| Sep 30, 2025 | $376.6M | +20.3% | −36.2% | −$77.7M | −$1.30 |
| Sep 30, 2024 | $313M | +27.7% | −70.6% | −$208.7M | −$3.60 |
| Sep 30, 2023 | $245.1M | +20.4% | −88.6% | −$204.6M | −$3.60 |
| Sep 30, 2022 | $203.6M | – | −115.3% | −$217.9M | −$4.04 |
Filings and dates
SEC EDGAR- Feb 1, 2027Next earnings reportexpected
- Nov 16, 2026Annual report10-K All filings
- Nov 12, 2026Earnings release, Q4 20268-K Press release
Also see TWST institutional ownership and the earnings calendar.
TWST earnings FAQ
What were TWST's latest earnings?
For Q4 2026 Twist Bioscience Corp reported revenue of $126.6M, GAAP EPS of -$0.32. The results were filed with the SEC on Nov 12, 2026.
When is TWST's next earnings date?
Twist Bioscience Corp is expected to report on Feb 1, 2027. Dates can move until the company confirms them.
Is TWST's revenue growing?
In the quarter ended Sep 30, 2026 revenue was $126.6M, up 27.9% from a year earlier. The table on this page shows every quarter from the company's 10-Q and 10-K filings.
Where do these numbers come from?
Results, guidance and financials come from Twist Bioscience Corp's own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.